Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser
Published: May 03, 2010
BUDAPEST, Hungary & SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)--James Chafouleas, Ph.D., former Head of Global Licensing – Virology at Boehringer Ingelheim Canada (Ltd.), has joined ViroStatics and Genetic Immunity as Strategic Adviser for Licensing and Business Development for both companies. Dr. Chafouleas brings over 20 years of “Big Pharma” experience in leading drug discovery, business development and licensing projects to his new position. The co-appointment of James Chafouleas comes in anticipation of the impending merger of Genetic Immunity and ViroStatics.